CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-26 | Gilman Michael Director | Exercise or conversion · Stock Option (Right to Buy) | −1,313 | 0 | ||
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion | +5,655 | $14.00 | $79K | 50,870 |
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion | +5,245 | $15.11 | $79K | 56,115 |
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion | +20,000 | $5.77 | $115K | 76,115 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −4,676 | $57.91 | $271K | 78,058 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −13,368 | $58.79 | $786K | 64,690 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −9,249 | $59.69 | $552K | 55,441 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −8,417 | $60.65 | $510K | 47,024 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −1,064 | $61.52 | $65K | 45,960 |
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion · Stock Option (Right to Buy) | −5,655 | 4,399 | ||
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion · Stock Option (Right to Buy) | −5,245 | 22,935 | ||
| 2021-01-26 | Carven Gregory John Head of Research | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 20,283 | ||
| 2020-07-16 | Kingsley Stuart A President and CEO | Grant or award · Stock Option (Right to Buy) | +429,684 | 429,684 | ||
| 2020-07-16 | Myles Edward H Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-06-16 | Burow Kristina Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-06-16 | Hallal David Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-06-16 | Hallal David Director | Grant or award · Stock Option (right to buy) | +7,000 | 7,000 | ||
| 2020-06-16 | FLIER JEFFREY S. Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-06-16 | Gilman Michael Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-06-16 | Myles Edward H Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 |
Page 26 of 33 · 642 trades